Lz. Solomon et al., EFFECTS OF SHORT-CHAIN FATTY-ACIDS ON PRIMARY UROTHELIAL CELLS IN CULTURE - IMPLICATIONS FOR INTRAVESICAL USE IN ENTEROCYSTOPLASTIES, The Journal of laboratory and clinical medicine, 132(4), 1998, pp. 279-283
Citations number
27
Categorie Soggetti
Medicine, General & Internal","Medicine, Research & Experimental","Medical Laboratory Technology
The presence of inflammatory changes and mucopus production in an ente
rocystoplasty may be similar to the condition of diversion colitis and
starvation diarrhea caused by a lack of luminal short-chain fatty aci
ds (SCFAs). We postulate a therapeutic role for intravesical SCFA, Bec
ause this treatment will also contact the urothelium, we have assessed
the effect on cellular proliferation by utilizing primary urothelial
cells in culture. Primary urothelial cells were grown from biopsy samp
les of normal urothelium obtained intraoperatively. A cocktail of SCFA
used in the treatment of diversion colitis was incubated with these c
ells for time intervals ranging from 30 minutes to 72 hours at drug co
ncentrations ranging from 0.04 to 20 mmol/L butyrate equivalent (BE),
The (4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) a
ssay was used to measure the residual viable biomass to assess growth
inhibition, These experiments were repeated on cells grown on matrigel
substrate. The human urothelial cancer line RT112 was likewise expose
d to SCFAs to assess selectivity between primary and transformed cells
. Primary urothelial cells in culture undergo growth inhibition when e
xposed to SCFAs, The concentration of SCFAs required to reduce the gen
eral biomass by 50% or more (IC greater than or equal to 50) was 20 mm
ol/L BE when exposure was for 2 hours or less, When drug exposure was
prolonged for 72 hours, the IC greater than or equal to 50 was 2.5 mmo
l/L BE. Cells grown on matrigel had their growth similarly inhibited.
The IC greater than or equal to 50 for the RT112 cell line was 2.5 mmo
l/L BE after 72 hours of drug incubation. Primary urothelial cells in
culture undergo a time- and dose-dependent growth inhibition when expo
sed to SCFAs. This inhibition is particularly apparent at the higher d
oses similar to those in use in clinical practice. Cells grown on a ma
trigel substrate suffer growth attenuation similar to that affecting c
ells grown on polystyrene plates. In vivo assessment in a rodent intra
vesical model is advisable before considering instillations in patient
s.